Advanced Search

Pathology/Lab Coding Alert

Path/Lab Coding:

Look to Neoplasm Codes for Inflammatory Breast Cancer Dx

Published on Wed Feb 26, 2025

Question: Our pathologist diagnosed inflammatory breast cancer. Should we report this using N61 instead of one of the usual codes we use for more common breast cancers, such as invasive ductal carcinoma (IDC) or ductal carcinoma in situ (DCIS)? Arizona Subscriber Answer: No, you would not use a genitourinary system code from N61.- (Inflammatory disorders of breast) for a confirmed [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert